A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
Clinical trial NCT04537949 · COMPLETED
Trial details
- NCT number
- NCT04537949
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2021-03-12
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.